![Jong-Gil Shin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 4 M $ au 31/05/2026
Jong-Gil Shin is currently the Chief Financial Officer, Director & Senior MD at Onconic Therapeutics, Inc. He holds an MBA from Tuck School of Business at Dartmouth.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/04/2026 | 329 365 ( 0,73% ) | 4 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ONCONIC THERAPEUTICS INC. | Directeur Financier/CFO | 01/01/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Onconic Therapeutics Co., Ltd.
 Onconic Therapeutics Co., Ltd. BiotechnologyHealth Technology Operates as a drug discovery and development company which develops therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
